In addition, the characteristic immunoprofiles of CD117, CD34, and DOG-1 immunoreactivities and C-KIT or PDGFRA mutations of GIST are adopted widely in routine pathological practice [82]. This evidence concerns the gene ANO1 and gastrointestinal stromal tumor.